Objective: The purpose of this study was to calculate the frequency of adverse fetal outcomes in oligohydramnios pregnancies. Study Design: Descriptive study Place and Duration: Department of Obstretics and Gynaecology,PUMHS Nawabshah Hospital. August 2018-February 2019 Methods: A total of 164 pregnant women with oligohydromnios were included in this study. Diagnosis was established after detailed history and abdominal examination. An extensive obstetric ultrasound was performed to verify the presence of alcohol, the baby's viability, the presence of two congenital defects, and the presence of the fetal heartbeat using Doppler ultrasonography. Information will then be filled in the performa. SPSS 22.0 was used to analyze all data. Results: The average age of the women was 25.76±4.18 years. Out of 164 cases, fetal growth retardation was observed in 39.02%, low birth weight 34.15%, NICU admission 30.5%, birth axpysia 27.44%, respiratory distress syndrome 12.8%, Apgar scores <7 at1 minutes 43.35% and at 5 minutes 23.2%, meconium aspiration syndrome 4.27% and perinatal mortality was observed in 4% . Conclusion: Assessment of AFI in the first part of the third trimester helps to identify women who need greater antepartum surveillance, and hence, correct care, to enhance perinatal outcome. Keywords: Oligohydramnios, Birth axpysia, Low birth weight
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.